The Immune System – Products

This article explores how cell-to-cell communication can be targeted for novel treatment methods.

Touchlight, announced a license agreement with GSK. This agreement grants GSK non-exclusive rights to use Touchlight’s proprietary enzymatic dbDNA™ (doggybone DNA™) technology for the development and production of mRNA-based products.

The overall solution for VZV vaccine R&D from manufacturing to clinical research, accompany you in the whole process of VZV vaccine development! Utilizing high-quality antigens, antibodies, and ELISA/ELISpot assay kits for both humoral and cellular immune assessment.

Harnessing the cytotoxic potential of T cells through immunotherapy has revolutionized cancer treatment, but the effectiveness of T-cell therapeutics is still limited in solid tumors.

On July 9th, 2024, the U.S. FDA approved Arcutis Biotherapeutics' ZORYVE® (roflumilast) for treating atopic dermatitis (AD), the most common type of eczema affecting millions in the U.S.

Consistent GMP-grade products are crucial as key raw materials for safe and reliable cell manufacturing. We adhere to stringent regulatory guidelines to provide high-quality GMP biomaterials for various cell culture and differentiation.

Partners to host joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK from 18–19 November 2024.

Yumizen H550 range expands to affordably introduce new applications and configurable hematology options for small to mid-throughput laboratories.

ioAstrocytes offer a solution to researchers who are searching for easy-to-use, highly characterised human cells that are designed for co-culture and effectively recapitulate astrocyte functions within CNS models in vitro

Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays.